– Delivery of CYB004 via inhalation showed significant advantages over intravenously administered dimethyltryptamine (“IV DMT”) in preclinical studies – — Rapid onset, longer duration of action and similar low variability achieved with single inhalation of CYB004 compared with IV DMT – – Inhaled CYB004 demonstrated more than 40% improved bioavailability over inhaled DMT –April 13, 2022 08:00 AM…


Previous articlePT309 – Jon Dennis, Esq. – Oregon’s Measure 109 and the Fight For Religious Liberty
Next articleMydecine Announces Reverse Stock-Split